These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33282864)
1. Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability. Poels K; Schnitzler JG; Waissi F; Levels JHM; Stroes ESG; Daemen MJAP; Lutgens E; Pennekamp AM; De Kleijn DPV; Seijkens TTP; Kroon J Front Cell Dev Biol; 2020; 8():581641. PubMed ID: 33282864 [TBL] [Abstract][Full Text] [Related]
2. Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis. Tillie RJHA; De Bruijn J; Perales-Patón J; Temmerman L; Ghosheh Y; Van Kuijk K; Gijbels MJ; Carmeliet P; Ley K; Saez-Rodriguez J; Sluimer JC Front Cell Dev Biol; 2021; 9():695684. PubMed ID: 34458258 [TBL] [Abstract][Full Text] [Related]
3. Gene-dosage effect of Pfkfb3 on monocyte/macrophage biology in atherosclerosis. Guo S; Li A; Fu X; Li Z; Cao K; Song M; Huang S; Li Z; Yan J; Wang L; Dai X; Feng D; Wang Y; He J; Huo Y; Xu Y Br J Pharmacol; 2022 Nov; 179(21):4974-4991. PubMed ID: 35834356 [TBL] [Abstract][Full Text] [Related]
4. PFKFB3 gene deletion in endothelial cells inhibits intraplaque angiogenesis and lesion formation in a murine model of venous bypass grafting. Perrotta P; de Vries MR; Peeters B; Guns PJ; De Meyer GRY; Quax PHA; Martinet W Angiogenesis; 2022 Feb; 25(1):129-143. PubMed ID: 34432198 [TBL] [Abstract][Full Text] [Related]
5. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis. Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464 [TBL] [Abstract][Full Text] [Related]
6. HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages. Tawakol A; Singh P; Mojena M; Pimentel-Santillana M; Emami H; MacNabb M; Rudd JH; Narula J; Enriquez JA; Través PG; Fernández-Velasco M; Bartrons R; Martín-Sanz P; Fayad ZA; Tejedor A; Boscá L Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1463-71. PubMed ID: 25882065 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. Mondal S; Roy D; Sarkar Bhattacharya S; Jin L; Jung D; Zhang S; Kalogera E; Staub J; Wang Y; Xuyang W; Khurana A; Chien J; Telang S; Chesney J; Tapolsky G; Petras D; Shridhar V Int J Cancer; 2019 Jan; 144(1):178-189. PubMed ID: 30226266 [TBL] [Abstract][Full Text] [Related]
8. PFKFB3 Regulates Chemoresistance, Metastasis and Stemness Jiang YX; Siu MKY; Wang JJ; Leung THY; Chan DW; Cheung ANY; Ngan HYS; Chan KKL Front Oncol; 2022; 12():748403. PubMed ID: 35155224 [TBL] [Abstract][Full Text] [Related]
9. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Milei J; Parodi JC; Fernandez Alonso G; Barone A; Beigelman R; Ferreira LM; Arrigoni G; Matturri L Cardiologia; 1996 Jun; 41(6):535-42. PubMed ID: 8766416 [TBL] [Abstract][Full Text] [Related]
10. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma. Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016 [TBL] [Abstract][Full Text] [Related]
11. Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension. Wang L; Zhang X; Cao Y; Ma Q; Mao X; Xu J; Yang Q; Zhou Y; Lucas R; Fulton DJ; Su Y; Barman SA; Hong M; Liu Z; Huo Y Br J Pharmacol; 2021 Mar; 178(5):1055-1072. PubMed ID: 33300142 [TBL] [Abstract][Full Text] [Related]
12. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215 [TBL] [Abstract][Full Text] [Related]
13. Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Keeter WC; Moriarty AK; Akers R; Ma S; Mussbacher M; Nadler JL; Galkina EV Front Cardiovasc Med; 2023; 10():1175673. PubMed ID: 37396582 [TBL] [Abstract][Full Text] [Related]
14. PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses. Sarkar Bhattacharya S; Thirusangu P; Jin L; Roy D; Jung D; Xiao Y; Staub J; Roy B; Molina JR; Shridhar V Cell Death Dis; 2019 Sep; 10(10):725. PubMed ID: 31562297 [TBL] [Abstract][Full Text] [Related]
15. SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice. Gurzeler E; Ruotsalainen AK; Laine A; Valkama T; Kettunen S; Laakso M; Ylä-Herttuala S PLoS One; 2021; 16(11):e0258408. PubMed ID: 34767557 [TBL] [Abstract][Full Text] [Related]
16. Monocarboxylate transporter 1 promotes classical microglial activation and pro-inflammatory effect via 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3. Kong L; Wang Z; Liang X; Wang Y; Gao L; Ma C J Neuroinflammation; 2019 Nov; 16(1):240. PubMed ID: 31779643 [TBL] [Abstract][Full Text] [Related]
17. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer. Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771 [TBL] [Abstract][Full Text] [Related]
18. Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture. Bobryshev YV; Killingsworth MC; Lord RS; Grabs AJ J Cell Mol Med; 2008 Oct; 12(5B):2073-82. PubMed ID: 18194456 [TBL] [Abstract][Full Text] [Related]
19. Hyperglycolysis in endothelial cells drives endothelial injury and microvascular alterations in peritoneal dialysis. Si Z; Su W; Zhou Z; Li J; Su C; Zhang Y; Hu Z; Huang Z; Zhou H; Cong A; Zhou Z; Cao W Clin Transl Med; 2023 Dec; 13(12):e1498. PubMed ID: 38037461 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death. Seijkens TTP; Poels K; Meiler S; van Tiel CM; Kusters PJH; Reiche M; Atzler D; Winkels H; Tjwa M; Poelman H; Slütter B; Kuiper J; Gijbels M; Kuivenhoven JA; Matic LP; Paulsson-Berne G; Hedin U; Hansson GK; Nicolaes GAF; Daemen MJAP; Weber C; Gerdes N; de Winther MPJ; Lutgens E Eur Heart J; 2019 Jan; 40(4):372-382. PubMed ID: 30452556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]